Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 2
2012 1
2013 1
2016 1
2017 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy.
Vargas C, Swartz D, Vashi A, Blasser M, Kasareian A, Cesaretti J, Kiley K, Terk M. Vargas C, et al. Brachytherapy. 2013 Mar-Apr;12(2):120-5. doi: 10.1016/j.brachy.2012.08.002. Epub 2012 Oct 10. Brachytherapy. 2013. PMID: 23062705 Clinical Trial.
PURPOSE: Evaluate outcomes and prognostic factors in men with localized prostate cancer. METHODS AND MATERIALS: A total of 3760 patients have undergone prostate seed implantation at our institution. This review is of our initial 304 conse …
PURPOSE: Evaluate outcomes and prognostic factors in men with localized prostate cancer. METHODS AND MATERIALS: …
Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy.
King MT, Nasser NJ, Mathur N, Cohen GN, Kollmeier MA, Yuen J, Vargas HA, Pei X, Yamada Y, Zakian KL, Zaider M, Zelefsky MJ. King MT, et al. Brachytherapy. 2016 May-Jun;15(3):266-273. doi: 10.1016/j.brachy.2016.02.003. Epub 2016 Apr 20. Brachytherapy. 2016. PMID: 27009848 Free PMC article.
PURPOSE: To report the long-term control and toxicity outcomes of patients with clinically localized prostate cancer, who underwent low-dose-rate prostate brachytherapy with magnetic resonance spectroscopic image (MRSI)-directed do …
PURPOSE: To report the long-term control and toxicity outcomes of patients with clinically localized prostate …
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer.
Machtens S, Baumann R, Hagemann J, Warszawski A, Meyer A, Karstens JH, Jonas U. Machtens S, et al. World J Urol. 2006 Aug;24(3):289-95. doi: 10.1007/s00345-006-0083-1. World J Urol. 2006. PMID: 16645877 Review.
Permanent interstitial brachytherapy represents the most conformal form of radiation therapy of the prostate and the number of patients with prostate cancers treated with permanent radioactive implants is increasing world wide. ...The ris …
Permanent interstitial brachytherapy represents the most conformal form of radiation therapy of the prostate and the nu …
Update on prostate brachytherapy: long-term outcomes and treatment-related morbidity.
Kao J, Cesaretti JA, Stone NN, Stock RG. Kao J, et al. Curr Urol Rep. 2011 Jun;12(3):237-42. doi: 10.1007/s11934-011-0183-3. Curr Urol Rep. 2011. PMID: 21399887 Review.
Current research in prostate brachytherapy focuses on five key concepts covered in this review. Transrectal ultrasound-guided prostate brachytherapy assisted by intraoperative treatment planning is the most advanced form of image-guided r …
Current research in prostate brachytherapy focuses on five key concepts covered in this review. Transrectal ultrasound-guided …
Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer.
Zelefsky MJ, Yamada Y, Pei X, Hunt M, Cohen G, Zhang Z, Zaider M. Zelefsky MJ, et al. Urology. 2011 Apr;77(4):986-90. doi: 10.1016/j.urology.2010.07.539. Epub 2010 Dec 31. Urology. 2011. PMID: 21195465 Free PMC article.
OBJECTIVES: To compare the long-term, prostate-specific antigen relapse-free survival outcome and incidence of toxicity for patients with low-risk prostate cancer who underwent brachytherapy or intensity-modulated radiotherapy (RT) …
OBJECTIVES: To compare the long-term, prostate-specific antigen relapse-free survival outcome and incidence of t …
Adaptive cone-beam CT planning improves long-term biochemical disease-free survival for (125)I prostate brachytherapy.
Peters M, Smit Duijzentkunst DA, Westendorp H, van de Pol SMG, Kattevilder R, Schellekens A, van der Voort van Zyp JRN, Moerland MA, van Vulpen M, Hoekstra CJ. Peters M, et al. Brachytherapy. 2017 Mar-Apr;16(2):282-290. doi: 10.1016/j.brachy.2016.11.018. Epub 2017 Jan 16. Brachytherapy. 2017. PMID: 28110899
PURPOSE: Determining the independent effect of additional intraoperative adaptive C-arm cone-beam CT (CBCT) planning vs. transrectal ultrasound (TRUS)-guided interactive planning alone in (125)I brachytherapy for prostate cancer (PCa) on biochem …
PURPOSE: Determining the independent effect of additional intraoperative adaptive C-arm cone-beam CT (CBCT) planning vs. trans …